论文部分内容阅读
目的分析和评价西藏自治区接受新发涂阳肺结核患者的治疗情况。方法查阅1994—2006年在西藏自治区7地(市)、74个县(区)、西藏自治区结核病防治研究所接受治疗管理的所有初治涂阳肺结核患者的治疗管理记录,分析初治涂阳病人的治疗结果。结果 1994—2006年初治涂阳肺结核患者采取全程管理短程化疗后的治愈率分别为33.3%、49.6%、48.0%、44.2%、67.1%、71.1%、82.3%、74.1%、82.5%、80.5%、76.5%、75.3%、81.3%。1994年DOTS策略覆盖率为0,1995年覆盖为5.30%,2005年起覆盖率达100%,结论 13年来大多数新发涂阳肺结核患者能够得到满意治疗结果 ,但离国家要求的85%治愈率还有差距,从中反映了对病人管理工作的重要性。
Objective To analyze and evaluate the treatment of newly diagnosed smear-positive pulmonary tuberculosis patients in the Tibet Autonomous Region. Methods The records of treatment management of all newly diagnosed smear positive pulmonary tuberculosis patients undergoing treatment and management in 7 prefectures (cities), 74 counties (autonomous regions) and TB Institute of Tibet Autonomous Region from 1994 to 2006 were analyzed. Treatment results. Results The cure rate of patients with smear positive pulmonary tuberculosis after the administration of short course chemotherapy was 33.3%, 49.6%, 48.0%, 44.2%, 67.1%, 71.1%, 82.3%, 74.1%, 82.5%, 80.5% , 76.5%, 75.3%, 81.3%. DOTS strategy coverage was 0 in 1994, covering 5.30% in 1995 and 100% coverage in 2005. Conclusions Most new smear-positive pulmonary tuberculosis patients have been satisfactorily treated over the past 13 years but are 85% of the nationally required cure rate There is still a gap between the rates and reflects the importance of patient management.